The introduction of biosimilars of low molecular weight heparins in Europe: a critical review and reappraisal endorsed by the Italian Society for Haemostasis and Thrombosis (SISET) and the Italian Society for Angiology and Vascular Medicine (SIAPAV)

Recently, the European Medicines Agency (EMA) authorized the introduction and marketing of Thorinane® and Inhixa®, biosimilars of the Low Molecular Weight Heparin (LMWH) enoxaparin. The authorization path is considerably different from the guidelines published by the EMA in 2009, as well as from the...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Thromb J
Hlavní autoři: Imberti, Davide, Marietta, Marco, Polo Friz, Hernan, Cimminiello, Claudio
Médium: Artigo
Jazyk:Inglês
Vydáno: BioMed Central 2017
Témata:
Review
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC5424282/
https://ncbi.nlm.nih.gov/pubmed/28490974
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12959-017-0136-2
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky